NFH
BLRX

NEXT Financial Holdings’s BioLineRX BLRX Stock Holding History

NEXT Financial Holdings’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$17K Buy
+67
New +$19.5K ﹤0.01% 995

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

NEXT Financial Holdings's BLRX Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in BioLineRX (BLRX) in Q1 2019: 67 shares worth $17K. The stake represents ﹤0.01% of the portfolio and ranks #995 among its holdings.

31 funds tracked by Wall St. Rank hold BLRX as of Q1 2019.

  • NEXT Financial Holdings held 67 shares of BioLineRX worth $17K as of Q1 2019.
  • BioLineRX was a new NEXT Financial Holdings position in Q1 2019.
  • BioLineRX made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #995 holding.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.